Zentalis Announces Preclinical Data Supporting Cyclin E1 As A Predictive Marker For Azenosertib Treatment At AACR Annual Meeting 2023

Data suggest Cyclin E1 plays a critical role in high proportion of multiple tumor types including platinum-resistant ovarian cancer Company anticipates sharing clinical data from ovarian chemotherapy... | April 17, 2023

Related Keywords

United States ,San Diego ,California ,New York ,Oregon ,American ,Julia Deutsch ,Mark Lackner ,Alexandra Roy ,Gordon Mills ,Exchange Commission ,Science University School Of Medicine ,Pharmaceuticals Inc ,Globenewswire Inc ,Pfizer Inc ,Clinical Research Excluding Trials ,Oregon Health ,Zentalis Pharmaceuticals ,Glaxosmithkline ,Solebury Strategic Communications ,Barrow Neurological Institute ,American Association For Cancer Research ,Ivy Brain Tumor Center ,Nasdaq ,Linkedin ,Cancer Research ,Annual Meeting ,Clinical Research Excluding ,Therapeutic Benefit ,Board Number ,Presentation Number ,Chief Translational Officer ,Cancer Biology ,Science University School ,Neurological Institute ,Efficacy Analysis ,Patient Derived Xenograft Models ,Molecular Therapeutics ,Integrated Discovery Engine ,Securities Litigation Reform Act ,Nc Stock Exchange ,News ,Information ,Press Release ,Data ,Uggest ,Cyclin ,1 ,Plays ,Critical ,Sole ,N ,Thigh ,Proportion ,F ,Multiple ,Humor ,Types ,Ncluding ,Ovarian ,Dancer ,Company ,Anticipates ,Sharing ,Linical ,Rom ,Varian Zntl Us98943l1070 ,